InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by KINGSLEY ALFRED D, Director. Officer active across 1 companies, notably Lineage Cell Therapeutics, Inc.. In total, 2 disclosures have been logged. The latest transaction was filed on 22 June 2021 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Declarations2 total
€113,90061,800 shares@ €1.8431100.0% of flow
Common Shares, no par value
SEC:0001493152-21-015072·
€113,90061,800 shares@ €1.84310.028% mcap50.0% of flow
Common Shares, no par value
SEC:0001493152-21-015072:0·
2 of 2 declarations
About KINGSLEY ALFRED D
Alfred D. Kingsley is a Director at Lineage Cell Therapeutics, Inc. He plays a key role in the governance and strategy of the company. Lineage Cell Therapeutics is a biopharmaceutical company focused on cell therapies. Alfred brings valuable expertise in the field, contributing to the company's direction and growth.
